ICL Misses On Sales And EPS As Growth Stalls, While Bromine Strength And A Guidance Lean Keep A 2027 Story Alive

ICL Group reported Q3 adjusted EPS of $0.10, missing estimates by 9.1%, with revenue of $1.91B, down 10.3% from consensus. Growth slowed across most segments except Industrial Products, which saw 18% sales growth. Management maintained full-year guidance, citing bromine strength and cost savings. Shares fell 11.4% post-earnings.

Original reporting
Published Nov 11, 2026, 4:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 9:07 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ICL Misses On Sales And EPS As Growth Stalls, While Bromine Strength And A Guidance Lean Keep A 2027 Story Alive — source image
Decision brief

The 30-second read

$ICLBearishMed
01

Why it matters

The earnings miss drives short‑term downside risk, but the company's industrial products segment and cost‑saving initiatives could support a recovery.

02

Market read

The earnings miss is material for traders holding or shorting ICL, with limited spillover to the broader sector.

03

What to watch

Sulfur cost decline and 2027 savings target may provide a longer‑term tailwind not reflected in the immediate price move.

Relevance 7/10Novelty 8/10Timing: after-hours

Background

ICL Group reported Q3 results that fell short of consensus, with revenue and EPS misses and slowing segment growth.

Company-level read

Ticker impact

$ICLBearishHigh confidence
Context

Q3 earnings miss on revenue and EPS, guidance unchanged, indicating near‑term pressure on the stock.

Expected impact

likely pressure as the market prices in weaker sales and EPS

Evidence & confidence

The company posted revenue $1.91B vs $2.13B consensus and EPS $0.10 vs $0.11 consensus, with guidance unchanged, prompting a negative reaction.

Market effects

Minerals sector may see broader scrutiny as growth stalls in diversified producers.

Potential impact on Israeli and broader Middle‑East commodity exporters.

Limited to investors in fertilizer and specialty chemicals.

Counterpoint

If industrial products sustain strong bromine pricing, the stock could rebound on the upside.

Key entities

  • ICL Group Ltd.

    Diversified minerals producer reporting Q3 earnings.

Related articles

$ICLMedAI 8/10

ICL Group Ltd (ICL) Q3 2026 Earnings Call Highlights: Industrial Strength and Cost Cuts

ICL Group Ltd reported Q3 2026 earnings, with CEO Elad Aronson and CFO Assaf discussing market outlook, segment performance, and cost management. Key points include stable potash demand, rising phosphate fertilizer demand, and falling sulfur prices. Industrial products sales rose 18% YoY to $347M, with EBITDA up nearly 50%. Potash EBITDA declined 7% YoY due to higher costs. The company expects 2026 EBITDA to be within the $1.5B-$1.7B guidance range, with relief from sulfur costs in 2027.

$ICLMed

ICL Group Ltd Q3 2026 Earnings Call Summary

ICL Group Ltd reported Q3 2026 earnings, highlighting growth from strategic price increases and high-margin products. Key segments showed mixed results: Industrial Products benefited from bromine price increases, Phosphate Solutions saw resilience in specialty products, and Potash margins faced pressure. The company expects 2026 EBITDA of $1.5B-$1.7B and $150M EBITDA improvement in 2027 from cost-cutting.

$ICLMedAI 8/10

ICL Group Q3 Earnings Call Highlights

ICL Group reported Q3 average potash price at $370/ton, up 5% YoY. Phosphate Solutions sales were $589M, EBITDA $118M. Growing Solutions sales were $538M, EBITDA $44M. Sulfur costs rose 220% YoY, impacting Q4. ICL expects $150M EBITDA improvement by 2027. Company to reorganize segments in 2027. Maintained 2026 potash sales forecast of 4.5-4.7M metric tons. Paid $63M dividend in Q3.

$ICLHighAI 8/10

ICL Group (ICL) Q3 2026 Earnings Call Transcript

ICL Group reported Q3 2026 adjusted net income of $126M, up 2%, with EPS at $0.10. Operating cash flow was $256M, and free cash flow was $66M. Industrial Products sales rose 18% YoY, driven by higher bromine prices. Potash sales increased 4% YoY, but EBITDA fell 7% due to cost pressures. Phosphate Solutions sales were $589M with a 20% EBITDA margin, despite higher raw material costs. Growing Solutions sales were $538M with EBITDA of $44M, facing market challenges in Brazil.